349 related articles for article (PubMed ID: 9135156)
1. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.
Whiteside ST; Epinat JC; Rice NR; Israƫl A
EMBO J; 1997 Mar; 16(6):1413-26. PubMed ID: 9135156
[TBL] [Abstract][Full Text] [Related]
2. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
4. Rel/NF-kappa B transcription factors and I kappa B inhibitors: evolution from a unique common ancestor.
Huguet C; Crepieux P; Laudet V
Oncogene; 1997 Dec; 15(24):2965-74. PubMed ID: 9416840
[TBL] [Abstract][Full Text] [Related]
5. Transcription of the RelB gene is regulated by NF-kappaB.
Bren GD; Solan NJ; Miyoshi H; Pennington KN; Pobst LJ; Paya CV
Oncogene; 2001 Nov; 20(53):7722-33. PubMed ID: 11753650
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
Hsing Y; Hostager BS; Bishop GA
J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of growth inhibition by GAL4-L kappa B-alpha in Saccharomyces cerevisiae.
Morin PJ; Downs JA; Snodgrass AM; Gilmore TD
Cell Growth Differ; 1995 Jul; 6(7):789-98. PubMed ID: 7547500
[TBL] [Abstract][Full Text] [Related]
9. Induction of nuclear factor-kappa B during primary B cell differentiation.
Kistler B; Rolink A; Marienfeld R; Neumann M; Wirth T
J Immunol; 1998 Mar; 160(5):2308-17. PubMed ID: 9498771
[TBL] [Abstract][Full Text] [Related]
10. I kappa B alpha can localize in the nucleus but shows no direct transactivation potential.
Cressman DE; Taub R
Oncogene; 1993 Sep; 8(9):2567-73. PubMed ID: 8361766
[TBL] [Abstract][Full Text] [Related]
11. A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.
Kamens J; Brent R
New Biol; 1991 Oct; 3(10):1005-13. PubMed ID: 1768648
[TBL] [Abstract][Full Text] [Related]
12. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription.
Suzuki T; Hirai H; Yoshida M
Oncogene; 1994 Nov; 9(11):3099-105. PubMed ID: 7936632
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100.
Dobrzanski P; Ryseck RP; Bravo R
Oncogene; 1995 Mar; 10(5):1003-7. PubMed ID: 7898917
[TBL] [Abstract][Full Text] [Related]
14. Human T cell leukemia virus type 1 tax protein increases NF-kappa B dimer formation and antagonizes the inhibitory activity of the I kappa B alpha regulatory protein.
Petropoulos L; Lin R; Hiscott J
Virology; 1996 Nov; 225(1):52-64. PubMed ID: 8918533
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
16. Cooperative binding and synergistic activation by RelA and C/EBPbeta on the intercellular adhesion molecule-1 promoter.
Catron KM; Brickwood JR; Shang C; Li Y; Shannon MF; Parks TP
Cell Growth Differ; 1998 Nov; 9(11):949-59. PubMed ID: 9831247
[TBL] [Abstract][Full Text] [Related]
17. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
[TBL] [Abstract][Full Text] [Related]
18. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
[TBL] [Abstract][Full Text] [Related]
19. Multiple redox regulation in NF-kappaB transcription factor activation.
Piette J; Piret B; Bonizzi G; Schoonbroodt S; Merville MP; Legrand-Poels S; Bours V
Biol Chem; 1997 Nov; 378(11):1237-45. PubMed ID: 9426183
[TBL] [Abstract][Full Text] [Related]
20. Tax protein of HTLV-1 destabilizes the complexes of NF-kappa B and I kappa B-alpha and induces nuclear translocation of NF-kappa B for transcriptional activation.
Suzuki T; Hirai H; Murakami T; Yoshida M
Oncogene; 1995 Mar; 10(6):1199-207. PubMed ID: 7700645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]